Portfolio company
VRNA
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
Verona Pharma develops inhaled therapeutics for adult patients with chronic respiratory diseases, primarily chronic obstructive pulmonary disease.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Verona Pharma
This biopharmaceutical company develops and commercialises inhaled medicines to treat chronic respiratory diseases for adult patients with conditions such as chronic obstructive pulmonary disease.
AirNexis Therapeutics
This company develops inhaled small molecule medicines to treat chronic obstructive pulmonary disease for patients with respiratory conditions.
AirNexis
This clinical-stage biotechnology company develops inhaled therapies for patients with chronic obstructive pulmonary disease and other respiratory conditions.
AQUILON PHARMACEUTICALS
The company develops inhaled medicines and nasal sprays for patients with asthma, chronic obstructive pulmonary disease and other respiratory conditions.
Kither Biotech
This company develops inhaled therapies for patients with respiratory diseases such as chronic obstructive pulmonary disease and cystic fibrosis.
Gossamer Bio
This biopharmaceutical company develops inhaled therapies for patients suffering from pulmonary arterial hypertension and interstitial lung disease.
Aer Therapeutics
This biopharmaceutical company develops inhaled mucolytic treatments for patients with muco-obstructive lung diseases, including chronic obstructive pulmonary disease and asthma.
Connect Biopharma
This clinical-stage biopharmaceutical company develops immune-modulating therapies for patients suffering from asthma and chronic obstructive pulmonary disease.